Since rare but severe clotting was seen in some people following vaccination with AstraZeneca’s Covid-19 vaccine, researchers worldwide have been grappling to understand why the clotting syndrome, known as “thrombosis with thrombocytopenia” (clotting with a low platelet count), occurs.
Melissa Davey brings you up to speed here:
All over-50s in England have been offered a coronavirus vaccine a few days before the mid-April deadline set by the government – meaning the second phase of the rollout to younger cohorts can now begin.
Despite fears of a supply slowdown and possible knock in confidence after a change in advice on who could get the Oxford/AstraZeneca jab, Boris Johnson hailed the passing of “another hugely significant milestone”.
With more than 32 million people now having had a first dose and 7.6 million of those having received their second, the prime minister said “many thousands of lives” had been saved.
Surge testing deployed in south London after South African variant found
at 3.35pm EDT